AlzeCure is part of the region’s world-leading research in healthy aging

Invest Stockholm has now updated its presentation of the region’s research and the companies working with neurodegenerative diseases. Here you will find, among others, AlzeCure, which is developing a painkiller based on this year’s Nobel Prize in Medicine.

Stockholm-Uppsala holds world-leading knowledge in the field of healthy aging. Invest Stockholm has made an extensive review of the region’s academic research in an updated report that also includes several selected companies.

Here is one of Flemingsberg’s knowledge companies: AlzeCure, which develops new innovative drug therapies for the treatment of severe diseases that affect the central nervous system, such as Alzheimer’s disease and pain.

The company is developing a painkiller based on a discovery by David Julius and Ardem Patapoutian who share this year’s Nobel Prize in Physiology or Medicine.

Read more about AlzeCure and the region’s leading research in the report: Improving Quality of Life for People with Neurodegenerative Diseases (pdf).

A Growing Arts and Cultural Scene in Flemingsberg

As Flemingsberg transforms into a city, a vibrant and dynamic arts and cultural scene is essential. Last spring, for the first time, over thirty individuals active in the cultural sector with ties to Flemingsberg gathered. This marked the starting point for a growing cultural cluster within one of Sweden's largest urban development projects.

Agnes Török: A Voice for Performance Poetry & Reading Promotion

With roots in Sweden and an international career, Agnes Török has established themselves as one of the most engaging voices in modern poetry. Agnes Török is Sweden's Reading Ambassador, a spoken word poet, and an author. Recently, they were also appointed as the lead instructor for the new university program in Performance Poetry and Storytelling at the Stockholm Institute of Music Education (SMI). 

ATMP Symposium for Knowledge Exchange, Innovation, and Future Collaborations

On January 22, 2025, NextGenNK and CCRM Nordic hosted a mini-symposium at Karolinska Institutet, Campus Flemingsberg, with a focus on Advanced Therapy Medicinal Products (ATMP). The event aimed to foster networking within the ATMP field and provide insights into both academic and commercial advancements in Stockholm and Sweden.

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

CF_logo_neg
2021-12-10T13:19:20+01:00
Go to Top